Personal information

No personal information available

Activities

Collapse all

Employment (1)

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine: Shanghai, CN

2020-12-01 to present | PI (Institute of Respiratory Diseases)
Employment
Source: Self-asserted source
Zhenhui Lu

Education and qualifications (1)

Shanghai University of Traditional Chinese Medicine: Shanghai, CN

2012-09-01 to 2015-07-01 | PhD (Longhua Medical College)
Education
Source: Self-asserted source
Zhenhui Lu

Professional activities (4)

Professional Branch of Integrated Traditional Chinese and Western Medicine of China Antituberculosis Association: Beijing, CN

2020 to 2022 | Secretary General
Membership
Source: Self-asserted source
Zhenhui Lu

Respiratory Medicine Research Association of China Association of Chinese Materia Medica: Beijing, CN

2019 to 2022 | Vice Chairman
Membership
Source: Self-asserted source
Zhenhui Lu

Chinese National Medical Association: Beijing, CN

2019 to 2022 | Standing director
Membership
Source: Self-asserted source
Zhenhui Lu

Respiratory Committee of World Federation of Chinese Medicine: Beijing, CN

2018 to 2022 | Deputy Secretary-General
Membership
Source: Self-asserted source
Zhenhui Lu

Funding (11)

Study on the mechanism of the protective effect of Qiangzhu Qinggan formula on lung injury based on the co-activation of airway epithelium and innate immunity in H1N1 infection

2022-01 to 2025-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Zhenhui Lu

Evidence-based research on the treatment of acute respiratory infectious diseases by TCM syndrome differentiation based on influenza as the model disease

2021-10 to 2024-09 | Grant
Shanghai Science and Technology Commission (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Construction, promotion and application of a plan for the treatment of drug-resistant pulmonary tuberculosis by Chinese and Western medicine

2021 to present | Award
Chinese Medical Association (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Multi-dimensional practice and nationwide application of combined treatment of refractory pulmonary tuberculosis with traditional Chinese and western medicine

2021 to present | Award
China Medical and Healthcare International Exchange Promotion Association (shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Clinical Application of Yanghe Dingchuan Ointment on Asthma- COPD Overlapping Syndrome

2020-10 to 2022-09 | Grant
Shanghai Hospital Development Center (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Technological Innovation and Application of Combined Treatment of Drug-resistant Pulmonary Tuberculosis with Traditional Chinese Medicine and Western Medicine

2020 to present | Award
Shanghai Municipal People's Government (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Mechanisms of Qingjin Granule-Mediated CTL / GzmB Immunosuppression Regulating Intracellular Escape / Colonization in MRSA Infected Mice

2019-01 to 2022-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Zhenhui Lu

Clinical Study on Treatment Program of Traditional Chinese Medicine for Anti-tuberculosis Drug-induced Liver Injury

2018-01 to 2021-12 | Grant
National Health Commission (Beijing, CN)
Source: Self-asserted source
Zhenhui Lu

The application and promotion of Professor Shao Changrong's series of anti-tuberculosis Chinese herbal medicines in the treatment of refractory pulmonary tuberculosis

2017 to present | Award
Shanghai Medical Association (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Study on immune mechanism of Qingjin granule in preventing and treating multi-drug resistant bacteria infection

2015-01 to 2017-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Zhenhui Lu

Professor Shao Changrong's clinical experience and development in the treatment of drug-resistant pulmonary tuberculosis

2010 to present | Award
Shanghai Medical Association (Shanghai, CN)
Source: Self-asserted source
Zhenhui Lu

Works (6)

Efficacy of integrating short-course chemotherapy with Chinese herbs to treat multi-drug resistant pulmonary tuberculosis in China: a study protocol.

Infectious diseases of poverty
2021-11-06 | Journal article
DOI: 10.1186/s40249-021-00913-5
PMID: 34742353
PMC: PMC8572065
Source: Self-asserted source
Zhenhui Lu

Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.

Frontiers in pharmacology
2021-07-09 | Journal article
DOI: 10.3389/fphar.2021.703724
PMID: 34305612
PMC: PMC8299004
Source: Self-asserted source
Zhenhui Lu

Linggan Wuwei Jiangxin formula ameliorates airway hyperresponsiveness through suppression of IL-1β and IL-17A expression in allergic asthmatic mice especially with diet-induced obesity.

Annals of translational medicine
2021-04-01 | Journal article
DOI: 10.21037/atm-21-1189
PMID: 33987380
PMC: PMC8106025
Source: Self-asserted source
Zhenhui Lu

Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.

Infectious diseases of poverty
2021-03-18 | Journal article
DOI: 10.1186/s40249-021-00813-8
PMID: 33731163
PMC: PMC7969149
Source: Self-asserted source
Zhenhui Lu

Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen.

Infectious diseases of poverty
2020-05-07 | Journal article
DOI: 10.1186/s40249-020-00660-z
PMID: 32381098
PMC: PMC7203794
Source: Self-asserted source
Zhenhui Lu

Efficacy of Jia Wei Yang He formula as an adjunctive therapy for asthma: study protocol for a randomized, double blinded, controlled trial.

Trials
2018-07-04 | Journal article
DOI: 10.1186/s13063-018-2739-8
PMID: 29973284
PMC: PMC6032802
Source: Self-asserted source
Zhenhui Lu

Peer review (7 reviews for 2 publications/grants)

Review activity for Journal of ethnopharmacology. (6)
Review activity for Military medical research. (1)
How many people are using ORCID?